Pharmaceuticals

Antiemetics And Antinauseants Market Research: Growth Projections and Trends 2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the antiemetics and antinauseants market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Antiemetics And Antinauseants Market’s size between 2026 and 2030?

The antiemetics and antinauseants market has shown consistent expansion in recent years. It is anticipated to grow from $8.48 billion in 2025 to $8.72 billion in 2026, maintaining a compound annual growth rate (CAGR) of 2.8%. The expansion witnessed in the historical period can be attributed to several factors, including an increase in cancer incidence, a rise in surgical procedures, growing awareness of chemotherapy side effects, the expansion of hospital and clinic infrastructure, and advancements in antiemetic drug formulations.

The antiemetics and antinauseants market size is anticipated to show steady growth over the next few years, expanding to $10.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.5%. This growth during the forecast period is attributable to the increasing prevalence of motion sickness, the expansion of the global geriatric population, rising adoption of personalized medicine, innovations in novel antiemetic drug delivery systems, and the broadening of outpatient chemotherapy and palliative care services. Noteworthy trends in the forecast period encompass the development of personalized anti-nausea therapies, new drug delivery systems, combination therapy approaches, growing demand for chemotherapy supportive care, and an increase in motion sickness and travel-related treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Which Drivers Are Shaping Strategic Decisions In The Antiemetics And Antinauseants Market?

The expanding occurrence of tuberculosis is anticipated to drive the demand for the antiemetics and antinauseants market. Tuberculosis (TB), an infectious bacterial condition mainly affecting the lungs, often necessitates anti-tuberculosis medications. These medications can induce nausea and vomiting, which antiemetics and antinauseants are used to manage. For instance, data from March 2025, provided by the US-based federal agency, Centers for Disease Control and Prevention, showed that in 2024, the United States recorded a provisional sum of 10,347 tuberculosis cases. This figure represents a rate of 3.0 cases per 100,000 population, marking an approximate 8% rise from 2023. Consequently, the rising prevalence of tuberculosis is projected to boost the growth of the antiemetics and antinauseants market.

What Segment Classifications Make Up The Antiemetics And Antinauseants Market?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Long-Term Trends Are Expected To Shape The Future Of The Antiemetics And Antinauseants Market?

Leading companies in the antiemetic and antinauseant markets are focusing on innovative product developments, such as ready-to-use injectables, to enhance treatment efficiency and improve patient adherence. These pre-prepared formulations aim to deliver immediate effectiveness, thereby reducing the time commitment and complexities often associated with conventional injectable medications. For example, in July 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, introduced FOCINVEZ, which is the first ready-to-use injectable formulation of fosaprepitant, developed to prevent both acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. This product is supplied in a 150 mg/50 mL vial, is free of Polysorbate 80, and requires no reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older, and it has been issued a unique J-Code (J1434) for reimbursement.

Which Leading Companies Dominate The Antiemetics And Antinauseants Market Share?

Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

How Does The Antiemetics And Antinauseants Market Perform Across Major Global Regions?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antiemetics And Antinauseants Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2026, By The Business Research Company

Antiemetics And Antinauseants Market Report 2026

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795